Drug Developments in Dementia

The existing drugs such as Cholinesterase inhibitors and Memantine are usually used to treat dementia and some other antidepressant also used with the treatments. Drugs are prescribed on the basis of severity of symptoms, such as mild-moderate dementia and moderate-severe dementia. New medications for dementia being developed in 2014/2015, 31% were named symptoms modifying. There are many developments are going on in drug discovery of dementia as old treatments are unable to stop the progression of dementia. Most associations share their exploration on new medications for dementia in dementia conferences to get higher esteem to their items. This gets to be distinctly gainful to different geriatric doctors to redesign themselves with such medications and progressing possibilities by going to dementia conferences. Such dementia meetings will help researchers to know target areas for drug development in dementia and work toward it.
  • Track 1-1 Cholinesterase inhibitors
  • Track 2-2 Memantine
  • Track 3-3 Medication for memory loss
  • Track 4-4 Beta and gamma secretase inhibitors
  • Track 5-5 Vitamin E and Omega-3-fatty acids
  • Track 6-6 New drug development in dementia

Related Conference of Neuroscience